ACADIA Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Purchase
VAN OSCH MARTIEN director
 Common Stock 366,501 $6.79 $2,488,542
Purchase
GORDON CARL L director
 Common Stock 359,603 $6.79 $2,441,704
Purchase
OXFORD BIOSCIENCE PARTNERS IV LP 10 percent owner
 Common Stock 586,402 $6.82 $3,999,848
Purchase
OXFORD BIOSCIENCE PARTNERS IV LP 10 percent owner
 Common Stock Warrant (right to buy) 146,600 $8.15 $1,194,497
Purchase
GORDON CARL L director
 Common Stock 150,000 $7 $1,050,000
Purchase
OXFORD BIOSCIENCE PARTNERS IV LP 10 percent owner
 Common Stock 285,000 $7 $1,995,000
Purchase
VAN OSCH MARTIEN director
 Common Stock 140,000 $7 $980,000
Purchase
WALTON ALAN G director
 Common Stock 285,000 $7 $1,995,000
Purchase
HACKSELL ULI director, officer: CEO
 Common Stock 300 $7 $2,100

Showing 850 to 859 of 859 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: